| Literature DB >> 34404575 |
N C Voermans1, M Vriens-Munoz Bravo2, G W Padberg3, P Laforêt4, N van Alfen, S Attarian, U A Badrising, P Bugiardini, P Camano González, R Y Carlier, I Desguerre, J Diaz-Manera, J Dumonceaux, B G van Engelen, T Evangelista, S Khosla, A Lópezde Munain, S M van der Maarel, A Mejat, M Monforte, F Montagnese, K Mul, P Oflazer, B Porter, S Quijano Roy, E Ricci, S Sacconi, V A Sansone, B Schoser, J Statland, E Stumpe, G Tasca, R Tawil, C Turner, J Vissing.
Abstract
Entities:
Keywords: Biomarkers; Clinical outcome measures; FSHD; Imaging outcome measures; Trial readiness
Year: 2021 PMID： 34404575 DOI： 10.1016/j.nmd.2021.07.013
Source DB: PubMed Journal: Neuromuscul Disord ISSN： 0960-8966 Impact factor: 4.296